NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …
Read More »
COPENHAGEN, Denmark, Aug. 31, 2020 /PRNewswire/ — H. Lundbeck A/S (Lundbeck) today announced headline results …
Read More »
SAN CARLOS, Calif., Sept. 2, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
CARMIEL, Israel, July 23, 2020 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), …
Read More »
WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the Phase 3 REACH3 study evaluating ruxolitinib (Jakafi®) …
Read More »
NEWARK, Calif., July 23, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage …
Read More »
NEW YORK and FARMINGTON, Conn., July 23, 2020 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
Lille (France), Cambridge (Massachusetts, United States), July 22, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a …
Read More »
FRANKLIN LAKES, N.J., July 22, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), …
Read More »
TOKYO & BASKING RIDGE, N.J. & MUNICH & VILLEJUIF, France–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, …
Read More »
VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the …
Read More »
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced …
Read More »
NORTH CHICAGO, Ill., July 21, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced upadacitinib (15 mg and …
Read More »
BOSTON–(BUSINESS WIRE)–Jnana Therapeutics today announced a strategic, multi-target collaboration and license agreement with Roche (SIX: RO, …
Read More »
THE WOODLANDS, Texas, July 21, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline …
Read More »
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 …
Read More »
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results of a global Phase 3 study of …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
